Protalix BioTherapeutics

PLX

Market cap $224M

45 hedge funds and large institutions have $3.53M invested in Protalix BioTherapeutics in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 20 reducing their positions, and 27 closing their positions.

Upgrade to unlock

New

Increased

Maintained

Reduced

Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

75% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 20

78% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 27

Holders

Holders Change

Holders Change %

% of All Funds

Holding in Top 10

–

Holding in Top 10 Change

Holding in Top 10 Change %

% of All Funds

New

Increased

Reduced

Closed

Calls

$62K

Puts

$37K

Net Calls

Net Calls Change

Top Buyers

1		+$284K
2		+$159K
3		+$77K
4	VF Virtu Financial New York	+$45.6K
5	SA Sanctuary Advisors Indianapolis, Indiana	+$39K

Top Sellers

1		-$460K
2		-$433K
3		-$390K
4	Jane Street New York	-$257K
5	YIH Y-Intercept (HK) Hong Kong	-$185K

#	Name	Holding
51	51	–
52	52	–
53	53	–
54	54	–
55	55	–
56	56	–
57	57	–
58	58	–
59	59	–
60	60	–
61	61	–
62	62	–
63	63	–
64	64	–
65	65	–
66	66	–
67	67	–
68	68	–
69	69	–
70	70	–
71	71	–
72	72	–

#	Name	Holding
51	51	–
52	52	–
53	53	–
54	54	–
55	55	–
56	56	–
57	57	–
58	58	–
59	59	–
60	60	–
61	61	–
62	62	–
63	63	–
64	64	–
65	65	–
66	66	–
67	67	–
68	68	–
69	69	–
70	70	–
71	71	–
72	72	–

#	Name	Holding
51	51	–
52	52	–
53	53	–
54	54	–
55	55	–
56	56	–
57	57	–
58	58	–
59	59	–
60	60	–
61	61	–
62	62	–
63	63	–
64	64	–
65	65	–
66	66	–
67	67	–
68	68	–
69	69	–
70	70	–
71	71	–
72	72	–

Protalix BioTherapeutics PLX Market cap $224M